BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7914043)

  • 1. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptics and the neuroleptic-induced deficit syndrome.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():8-13. PubMed ID: 7914056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced deficit syndrome (NIDS).
    J Clin Psychiatry; 1993 Dec; 54(12):493-500. PubMed ID: 7903967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic induced deficit syndrome].
    Szafrański T
    Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does affective blunting in schizophrenia reflect affective deficit or neuromotor dysfunction?
    Dworkin RH; Clark SC; Amador XF; Gorman JM
    Schizophr Res; 1996 Jul; 20(3):301-6. PubMed ID: 8827857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms in schizophrenia: assessment of the effect of risperidone.
    Schooler NR
    J Clin Psychiatry; 1994 May; 55 Suppl():22-8. PubMed ID: 7520905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.
    Kirkpatrick B; Buchanan RW; McKenney PD; Alphs LD; Carpenter WT
    Psychiatry Res; 1989 Nov; 30(2):119-23. PubMed ID: 2616682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing systems for assessment of negative symptoms in schizophrenia.
    Fenton WS; McGlashan TH
    Arch Gen Psychiatry; 1992 Mar; 49(3):179-84. PubMed ID: 1567273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
    Petit M; Langlois S
    Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():115-21. PubMed ID: 8866773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positive or negative symptoms. Which are more reliable in the diagnosis of schizophrenia?].
    Klosterkötter J; Albers M; Steinmeyer EM; Hensen A; Sass H
    Nervenarzt; 1994 Jul; 65(7):444-53. PubMed ID: 7800088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of activation procedures on neuroleptic-induced akathisia.
    Fleischhacker WW; Miller CH; Barnas C; Bergmann K; Perovich R; Alvir JM; Lieberman JA; Kane JM
    Br J Psychiatry; 1993 Dec; 163():781-4. PubMed ID: 7905775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():64-7. PubMed ID: 7914053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.